Zoledronic acid enhances lipopolysaccharide-stimulated proinflammatory reactions through controlled expression of SOCS1 in macrophages.
about
Myeloid-derived cells are key targets of tumor immunotherapyHyperbaric oxygen therapy and osteonecrosis.Immune cell profile of dental pulp tissue treated with zoledronic acid.Preexisting Periapical Inflammatory Condition Exacerbates Tooth Extraction-induced Bisphosphonate-related Osteonecrosis of the Jaw Lesions in Mice.Suppression of microRNA-155 attenuates neuropathic pain by regulating SOCS1 signalling pathway.Macrophages and bisphosphonate-related osteonecrosis of the jaw (BRONJ): evidence of local immunosuppression of macrophages in contrast to other infectious jaw diseases.Zoledronate dysregulates fatty acid metabolism in renal tubular epithelial cells to induce nephrotoxicity.Chronic treatment with zoledronic acid increases inflammatory markers in periodontium of rats.Immune cellular profile of bisphosphonate-related osteonecrosis of the jaw.Intraoperative detection of viable bone with fluorescence imaging using Visually Enhanced Lesion Scope in patients with bisphosphonate-related osteonecrosis of the jaw: clinical and pathological evaluation.Anti-inflammatory effect of polydeoxyribonucleotide on zoledronic acid-pretreated and lipopolysaccharide-stimulated RAW 264.7 cells.Zoledronic acid exacerbates inflammation through M1 macrophage polarization.Pathogenesis of medication-related osteonecrosis of the jaw: a comparative study of in vivo and in vitro trials
P2860
Q28388246-36785191-F47C-4609-9584-64CFF13611D2Q38803408-CEDA38D6-955C-4C9F-8AFC-D4DE9D25F855Q39098260-9AABAEB9-BDD4-4F61-A8C1-E869BD1B9DBBQ40509688-61EC8B11-A885-46FB-BE3F-47B51244581EQ41714041-953E235C-A4D3-4741-B6B0-36B3E0143A79Q42209228-F1AC007F-C613-4C0C-BB34-C98540D8CE86Q47856782-407E9FC4-DB8E-4704-A11D-8D14118988B3Q48136878-D1F8AEA6-BD84-4E6C-97C0-69ACFF47A660Q48220380-6F6DF5D6-A029-4E7B-84CC-EE89544E4666Q50969537-24EFC4D1-1EC8-4DC9-BA37-0C6B686D4A39Q55244759-1E9E6F57-279D-4639-8FE5-0558F1C292F4Q55453523-119B973D-55A2-4092-8E9D-AB15892463FEQ58791940-1AF1C95D-8318-4D45-8DA5-864516614224
P2860
Zoledronic acid enhances lipopolysaccharide-stimulated proinflammatory reactions through controlled expression of SOCS1 in macrophages.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Zoledronic acid enhances lipop ...... ssion of SOCS1 in macrophages.
@en
Zoledronic acid enhances lipop ...... ssion of SOCS1 in macrophages.
@nl
type
label
Zoledronic acid enhances lipop ...... ssion of SOCS1 in macrophages.
@en
Zoledronic acid enhances lipop ...... ssion of SOCS1 in macrophages.
@nl
prefLabel
Zoledronic acid enhances lipop ...... ssion of SOCS1 in macrophages.
@en
Zoledronic acid enhances lipop ...... ssion of SOCS1 in macrophages.
@nl
P2093
P2860
P1433
P1476
Zoledronic acid enhances lipop ...... ssion of SOCS1 in macrophages.
@en
P2093
Akinobu Matsumoto
Daichi Muratsu
Daigo Yoshiga
Seiji Nakamura
Takaharu Taketomi
Tomohiro Onimura
Yoshihiro Seki
P2860
P304
P356
10.1371/JOURNAL.PONE.0067906
P407
P577
2013-07-09T00:00:00Z